Travere Therapeutics (TVTX) News Today $16.94 +0.03 (+0.18%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$16.95 +0.01 (+0.06%) As of 08/8/2025 04:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TVTX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Travere Therapeutics price target raised to $32 from $30 at WedbushAugust 8 at 6:27 PM | finance.yahoo.comTravere Therapeutics (NASDAQ:TVTX) Given New $31.00 Price Target at ScotiabankAugust 8 at 4:14 PM | marketbeat.comWedbush Boosts Travere Therapeutics (NASDAQ:TVTX) Price Target to $32.00August 8 at 8:41 AM | marketbeat.comTravere Therapeutics shares rise as Q2 results top expectationsAugust 7 at 4:00 AM | investing.comTravere Therapeutics Reports Strong Q2 2025 GrowthAugust 7 at 4:00 AM | msn.comTravere Therapeutics, Inc. (TVTX) Q2 2025 Earnings Call TranscriptAugust 6 at 12:01 AM | seekingalpha.comTravere Therapeutics, Inc. 2025 Q2 - Results - Earnings Call PresentationAugust 6 at 8:42 PM | seekingalpha.comEarnings Preview: Travere TherapeuticsAugust 5, 2025 | benzinga.comXTX Topco Ltd Has $935,000 Position in Travere Therapeutics, Inc. (NASDAQ:TVTX)August 4, 2025 | marketbeat.comShort Interest in Travere Therapeutics, Inc. (NASDAQ:TVTX) Rises By 857,233.3%August 3, 2025 | americanbankingnews.comTravere Therapeutics, Inc. (NASDAQ:TVTX) Short Interest UpdateAugust 2, 2025 | marketbeat.comTravere Therapeutics (TVTX) Expected to Announce Earnings on ThursdayJuly 31, 2025 | marketbeat.comTravere Therapeutics to Report Second Quarter 2025 Financial ResultsJuly 30, 2025 | businesswire.comEssex Investment Management Co. LLC Makes New Investment in Travere Therapeutics, Inc. (NASDAQ:TVTX)July 29, 2025 | marketbeat.comUniversal Beteiligungs und Servicegesellschaft mbH Has $6.07 Million Position in Travere Therapeutics, Inc. (NASDAQ:TVTX)July 28, 2025 | marketbeat.com32,731 Shares in Travere Therapeutics, Inc. (NASDAQ:TVTX) Acquired by Legato Capital Management LLCJuly 26, 2025 | marketbeat.comBank of New York Mellon Corp Boosts Stake in Travere Therapeutics, Inc. (NASDAQ:TVTX)July 26, 2025 | marketbeat.comJennison Associates LLC Increases Position in Travere Therapeutics, Inc. (NASDAQ:TVTX)July 21, 2025 | marketbeat.comTravere Therapeutics, Inc. (NASDAQ:TVTX) Receives Consensus Rating of "Moderate Buy" from BrokeragesJuly 18, 2025 | marketbeat.comWedbush Forecasts Reduced Earnings for Travere TherapeuticsJuly 17, 2025 | marketbeat.comWedbush Expects Lower Earnings for Travere TherapeuticsJuly 16, 2025 | marketbeat.comEmerald Advisers LLC Lowers Holdings in Travere Therapeutics, Inc. (NASDAQ:TVTX)July 13, 2025 | marketbeat.comEmerald Mutual Fund Advisers Trust Increases Stock Position in Travere Therapeutics, Inc. (NASDAQ:TVTX)July 12, 2025 | marketbeat.comTravere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)July 11, 2025 | businesswire.com109,542 Shares in Travere Therapeutics, Inc. (NASDAQ:TVTX) Purchased by Penserra Capital Management LLCJuly 8, 2025 | marketbeat.comLeerink Partners Reiterates a Bullish Stance on Travere Therapeutics (TVTX)July 6, 2025 | insidermonkey.comLeerink Partners Reiterates a Bullish Stance on Travere Therapeutics (TVTX)July 6, 2025 | msn.comInsider Selling: Travere Therapeutics, Inc. (NASDAQ:TVTX) Insider Sells 815 Shares of StockJuly 3, 2025 | insidertrades.comQ2 EPS Estimate for Travere Therapeutics Cut by AnalystJuly 3, 2025 | marketbeat.comJula Inrig Sells 815 Shares of Travere Therapeutics, Inc. (NASDAQ:TVTX) StockJuly 2, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Travere Therapeutics, Inc. - TVTXJuly 2, 2025 | prnewswire.com1TVTX : Demystifying Travere Therapeutics: Insights From 8 Analyst ReviewsJuly 2, 2025 | benzinga.comTravere Therapeutics (NASDAQ:TVTX) Given Buy Rating at HC WainwrightJuly 1, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Travere Therapeutics, Inc. - TVTX - MorningstarJune 29, 2025 | morningstar.comMTravere Therapeutics Inc News (TVTX) - Investing.comJune 27, 2025 | investing.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Travere Therapeutics, Inc. - TVTXJune 23, 2025 | globenewswire.comTravere Therapeutics, Inc. (NASDAQ:TVTX) Given Average Rating of "Moderate Buy" by BrokeragesJune 23, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Travere Therapeutics, Inc. - TVTXJune 22, 2025 | prnewswire.comEquities Analysts Set Expectations for TVTX FY2025 EarningsJune 16, 2025 | marketbeat.comWhat is HC Wainwright's Estimate for TVTX Q2 Earnings?June 16, 2025 | marketbeat.comTravere Therapeutics’ SWOT analysis: rare disease stock faces regulatory hurdlesJune 15, 2025 | investing.comAssenagon Asset Management S.A. Sells 116,999 Shares of Travere Therapeutics, Inc. (NASDAQ:TVTX)June 15, 2025 | marketbeat.comHC Wainwright Starts Travere Therapeutics, Inc. (TVTX) at Buy on FILSPARI BreakthroughsJune 14, 2025 | finance.yahoo.comHC Wainwright Starts Travere Therapeutics, Inc. (TVTX) at Buy on FILSPARI BreakthroughsJune 13, 2025 | insidermonkey.comQ4 EPS Estimate for Travere Therapeutics Lowered by AnalystJune 13, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Travere Therapeutics, Inc. - TVTXJune 12, 2025 | prnewswire.comCantor Fitzgerald Predicts TVTX FY2026 EarningsJune 11, 2025 | marketbeat.comTravere Therapeutics (NASDAQ:TVTX) Given "Buy" Rating at HC WainwrightJune 11, 2025 | marketbeat.comCitigroup Issues Pessimistic Forecast for Travere Therapeutics (NASDAQ:TVTX) Stock PriceJune 11, 2025 | marketbeat.comTravere Therapeutics to Present New FILSPARI® (sparsentan) Data at the 15th International Podocyte ConferenceJune 11, 2025 | businesswire.com Get Travere Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TVTX and its competitors with MarketBeat's FREE daily newsletter. Email Address TVTX Media Mentions By Week TVTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TVTX News Sentiment▼0.730.38▲Average Medical News Sentiment TVTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TVTX Articles This Week▼147▲TVTX Articles Average Week Get Travere Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TVTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Axsome Therapeutics News Today Lantheus News Today CRISPR Therapeutics News Today ADMA Biologics News Today Abivax News Today Merus News Today Krystal Biotech News Today Telix Pharmaceuticals News Today Cytokinetics News Today Avidity Biosciences News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TVTX) was last updated on 8/9/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredFOUR TRILLION DOLLARS!Nvidia just became the first company in history to hit a $4 trillion valuation—surpassing Apple and Microsoft....Porter & Company | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Travere Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Travere Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TVTX Stock Alerts